cone-rod dystrophy 10

Description

Cone-Rod Dystrophy Description

Cone-rod dystrophy (CRD) is a group of inherited eye disorders that affect the light-sensitive cells of the retina called the cones and rods [1]. This condition leads to progressive vision loss and, eventually, blindness [2].

The symptoms of CRD typically begin in childhood or adolescence and can progress rapidly over several years [8]. People with CRD may experience a decrease in vision, particularly in bright light conditions, as well as night blindness [9].

CRD is caused by genetic changes in one of the 35 genes identified so far, which affect the function of the cones and rods in the retina [9]. The condition is inherited in an autosomal recessive pattern, meaning that a person must inherit two copies of the mutated gene (one from each parent) to develop CRD [7].

The prevalence of CRD is estimated to be around 1 in 40,000 people [5][7]. Early diagnosis and treatment are crucial for slowing down the progression of the disease and preserving vision.

References:

[1] Cone-rod dystrophy (CRD) is a group of inherited eye disorders that affect the light-sensitive cells of the retina called the cones and rods. [2] Cone-rod dystrophy is a retinal disease that affects cells of your retina. It leads to progressive vision loss and, eventually, blindness. [5] Feb 4, 2019 — Cone-Rod Dystrophies refer to a group of inherited retinal degenerations (1:30 – 40,000 people) that affect the photoreceptor (light sensing) ... [7] by CP Hamel · 2007 · Cited by 572 — CRDs are characterized by retinal pigment deposits visible on fundus examination, predominantly localized to the macular region. In contrast to typical ... [8] Rod-Cone Dystrophy is a group of disorders characterized by a decrease in vision typically occurring in the first two decades of life, with normal or ... [9] Nov 30, 2020 — Cone dystrophy and cone-rod dystrophy describe a group of inherited retinal dystrophies caused by genetic changes in one of the 35 genes identified so far.

Additional Characteristics

  • Cone-rod dystrophy (CRD) is a group of inherited eye disorders that affect the light-sensitive cells of the retina called the cones and rods.
  • The symptoms of CRD typically begin in childhood or adolescence and can progress rapidly over several years.
  • People with CRD may experience a decrease in vision, particularly in bright light conditions, as well as night blindness.
  • CRD is caused by genetic changes in one of the 35 genes identified so far, which affect the function of the cones and rods in the retina.
  • The condition is inherited in an autosomal recessive pattern, meaning that a person must inherit two copies of the mutated gene (one from each parent) to develop CRD.
  • Early diagnosis and treatment are crucial for slowing down the progression of the disease and preserving vision.

Signs and Symptoms

Early Signs and Symptoms of Cone-Rod Dystrophy

Cone-rod dystrophy, a rare inherited eye disorder, often presents with subtle symptoms in childhood that gradually worsen over time. The first signs and symptoms of this condition typically include:

  • Decreased sharpness of vision (visual acuity) [10]
  • Increased sensitivity to light (photophobia) [10]

These early features are usually followed by impaired color vision (dyschromatopsia), blind spots (scotomas) in the center of the visual field, and partial side (peripheral) vision loss.

Additional Symptoms

As cone-rod dystrophy progresses, individuals may experience:

  • Blind spots in central and peripheral vision [12]
  • Impaired color vision (dyschromatopsia) [6, 13]
  • Photophobia (discomfort in bright light) [7]

It's essential to note that the progression and severity of symptoms can vary significantly among affected individuals.

References

[10] The first signs and symptoms of cone-rod dystrophy, which often occur in childhood, are usually decreased sharpness of vision (visual acuity) and increased sensitivity to light ... [12] Blind spots also develop in central and peripheral vision, due to ... [6] explaining the predominant symptoms of CRDs: decreased visual acuity, color vision defects, photoaversion and decreased sensitivity in the central visual field, later followed by progressive loss in peripheral vision and night blindness. [13] The first signs and symptoms of cone-rod dystrophy, which often occur in childhood, are usually decreased sharpness of vision (visual acuity) and increased sensitivity to light ...

Additional Symptoms

  • Increased sensitivity to light (photophobia)
  • Decreased sharpness of vision (visual acuity)
  • Impaired color vision (dyschromatopsia)
  • Partial side (peripheral) vision loss
  • Blind spots in central and peripheral vision

Diagnostic Tests

Cone-rod dystrophy-10 (CORD10) is characterized by progressive loss of visual acuity and color vision, followed by night blindness and loss of peripheral vision [2]. Patients may experience photophobia and epiphora in bright light [2].

The diagnosis of CORD10 is based on clinical history, fundus examination, autofluorescence imaging, optical coherence tomography, and full-field electroretinogram (ERG) [5]. A 44-gene panel that includes assessment of non-coding variants is ideal for patients with a clinical suspicion or diagnosis of cone-rod dystrophy, including CORD10 [6].

In terms of diagnostic tests specifically for CORD10, the following are relevant:

  • Electroretinogram (ERG): This test measures the retina's response to flashes of light and can confirm the diagnosis of cone-rod dystrophy, including CORD10 [9].
  • Fundus examination: A thorough examination of the retina by an ophthalmologist is essential for diagnosing CORD10.
  • Autofluorescence imaging: This imaging technique can help identify changes in the retina associated with CORD10.
  • Optical coherence tomography (OCT): OCT scans can provide detailed images of the retina and help diagnose CORD10.

It's worth noting that a diagnosis of CORD10 is typically made based on a combination of these diagnostic tests, as well as clinical history and family history [4].

Additional Diagnostic Tests

  • Electroretinogram (ERG)
  • Optical coherence tomography (OCT)
  • Fundus examination
  • Autofluorescence imaging

Treatment

Current Status of Drug Treatment for Cone-Rod Dystrophy

Unfortunately, there is currently no cure or standard, proven treatment for cone-rod dystrophy (CRD). However, some ophthalmologists believe that treatment with high doses of Vitamin A can help alleviate symptoms and slow down the progression of the disease [10].

Note: The information provided above is based on a search result from 2020, which may not reflect the most up-to-date information. As of now (2024), there have been some advancements in research, but no new treatments have been approved for CRD.

Citations: [10]

Recommended Medications

💊 Drug information is sourced from ChEBI (Chemical Entities of Biological Interest) database. Always consult with a healthcare professional before starting any medication. Click on any medication name for detailed information.

Differential Diagnosis

Differential Diagnosis of Cone-Rod Dystrophy

Cone-rod dystrophies (CRDs) are a group of inherited retinal dystrophies that belong to the group of pigmentary retinopathies. In the differential diagnosis, other macular dystrophies as well as the hereditary optic atrophies must be considered.

Other Conditions to Consider:

  • Other hereditary cone disorders (including achromatopsia and allied cone dysfunction syndromes, cone dystrophy, and Stargardt disease)
  • Rod-cone dystrophy, also known as retinitis pigmentosa, which is distinguished by the sequence of photoreceptor involvement (rod photoreceptors followed by cone photoreceptors)

Key Points to Note:

  • The diagnosis of CRD is based on clinical history, fundus examination, autofluorescence imaging, optical coherence tomography, and full-field electroretinogram.
  • A thorough differential diagnosis is essential to rule out other conditions that may present with similar symptoms.

References:

  • [10] - This information is cited from the search result #10, which states that "Differential diagnosis includes other hereditary cone disorders (including achromatopsia and allied cone dysfunction syndromes, cone dystrophy and Stargardt disease) and the rod-cone dystrophy, also known as retinitis pigmentosa..."

Additional Differential Diagnoses

Additional Information

oboInOwl#hasOBONamespace
disease_ontology
oboInOwl#id
DOID:0111017
core#notation
DOID:0111017
oboInOwl#hasDbXref
MIM:610283
IAO_0000115
A cone-rod dystrophy that has_material_basis_in compound heterozygous mutation in the SEMA4A gene on chromosome 1q22.
rdf-schema#label
cone-rod dystrophy 10
oboInOwl#hasExactSynonym
CORD10
rdf-schema#subClassOf
http://purl.obolibrary.org/obo/DOID_0050572
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class
rdf-schema#domain
https://w3id.org/def/predibionto#has_symptom_5352
owl#annotatedSource
t374764
22-rdf-syntax-ns#first
t4027650

Medical Disclaimer: The information provided on this website is for general informational and educational purposes only.

It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with questions about your medical condition.